Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Budesonide/mercaptopurine/prednisolone

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gummlich BPM, et al. Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. American Journal of Case Reports 23: 2022. Available from: URL: http://doi.org/10.12659/AJCR.938272 Gummlich BPM, et al. Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. American Journal of Case Reports 23: 2022. Available from: URL: http://​doi.​org/​10.​12659/​AJCR.​938272
Metadaten
Titel
Budesonide/mercaptopurine/prednisolone
Various toxicities: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30482-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Valproic-acid

Case report

Cisplatin

Case report

Multiple drugs

Case report

Antibacterials